Skip to main content

Comprehensive assessment of erenumab efficacy in subjects with high frequency episodic migraine with at least 1 previously failed preventive treatment: a clobal, double-blind, placebo-controlled phase 4 study.

Open
  • Protocol code: 20190008
  • EudraCT code: 2019-003646-33
  • Research group: Headache and Neurological Pain
  • Service: Neurology
  • Principal investigator:  Pozo Rosich, Patricia
  • Pathology: Malalties del sistema nerviós
  • Phase: Fase IV
  • Status: Recruiting volunteers